Varadan Anand 4
4 · Karyopharm Therapeutics Inc. · Filed Jun 25, 2018
Insider Transaction Report
Form 4
Varadan Anand
EVP, Chief Commercial Officer
Transactions
- Award
Nonstatutory Stock Option (right to buy)
2018-06-22+150,000→ 150,000 totalExercise: $18.68Exp: 2028-06-21→ Common Stock (150,000 underlying)
Footnotes (1)
- [F1]This option was granted on June 22, 2018. The shares underlying this option vest as to 25% of the shares on June 22, 2019, with the remaining 75% vesting in 36 equal monthly installments.